x

ProMIS Neurosciences Inc. (Nasdaq:PMN)

Health Care/Life Sciences • Biotechnology
CIK 1374339
Company

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Address
1920 Yonge Street
Suite 200
Toronto, Ontario M4S 3E2
Employees
7
Stock Info
Close
$1.9700
Day Range
1.9500 - 2.1800
52 Week Range
0.9500 - 8.9500
Average volume
48.61K
Short Interest
18.39K (02/15/24)
% of Float Shorted
0.28%
Market Cap
$41.55M
Revenue
N/A
Net Income
-$18.06M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.9463
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Eugene Williams MBA
President, Chief Executive Officer & Director
Neil K Warma MBA
Director & Chief Scientific Officer
Neil R Cashman MD
Independent Director
Patrick D Kirwin
Lead Independent Director
Maggie Shafmaster PhD
Independent Director
William W Wyman MBA
Independent Director
Josh Mandel-Brehm MBA
SEC filings
DateFormEvent
29 Aug, 2024 S-3
29 Aug, 2024 PRE 14A
16 Aug, 2024 4
8 Aug, 2024 8-K
8 Aug, 2024 10-Q
5 Aug, 2024 SC 13G
2 Aug, 2024 4
2 Aug, 2024 4
2 Aug, 2024 4
29 Jul, 2024 8-K
26 Jul, 2024 8-K
26 Jul, 2024 8-K
5 Jul, 2024 8-K
14 Jun, 2024 8-K
14 May, 2024 8-K
14 May, 2024 10-Q
30 Apr, 2024 8-K
25 Apr, 2024 DEFA14A
25 Apr, 2024 DEF 14A
25 Apr, 2024 ARS
1 Apr, 2024 424B5
1 Apr, 2024 8-K
1 Apr, 2024 10-K
5 Feb, 2024 SC 13G/A
5 Jan, 2024 8-K
5 Jan, 2024 424B5
5 Jan, 2024 4
3 Jan, 2024 8-K CEO Change
2 Jan, 2024 4
2 Jan, 2024 SC 13G/A
27 Dec, 2023 3
27 Dec, 2023 3
27 Dec, 2023 SC 13G/A
8 Dec, 2023 8-K
20 Nov, 2023 8-K
14 Nov, 2023 8-K
14 Nov, 2023 10-Q
30 Oct, 2023 4
30 Oct, 2023 4
30 Oct, 2023 4
30 Oct, 2023 4
30 Oct, 2023 4
30 Oct, 2023 4
29 Sep, 2023 EFFECT
29 Sep, 2023 EFFECT
27 Sep, 2023 CORRESP
27 Sep, 2023 CORRESP
27 Sep, 2023 S-3/A
27 Sep, 2023 S-3/A
25 Sep, 2023 UPLOAD
25 Sep, 2023 EFFECT
25 Sep, 2023 UPLOAD
22 Sep, 2023 S-3
22 Sep, 2023 S-3
22 Sep, 2023 POS AM
5 Sep, 2023 SC 13G/A
5 Sep, 2023 SC 13G/A
5 Sep, 2023 3
30 Aug, 2023 SC 13G
25 Aug, 2023 4
25 Aug, 2023 4
25 Aug, 2023 4
25 Aug, 2023 4
25 Aug, 2023 4
22 Aug, 2023 424B3
22 Aug, 2023 8-K
14 Aug, 2023 8-K
14 Aug, 2023 424B3
14 Aug, 2023 10-Q
10 Jul, 2023 8-K
10 Jul, 2023 424B3
30 Jun, 2023 424B3
30 Jun, 2023 8-K
1 Jun, 2023 ARS
1 Jun, 2023 DEF 14A
22 May, 2023 PRE 14A
18 May, 2023 424B3
15 May, 2023 8-K
15 May, 2023 10-Q
8 May, 2023 424B3
8 May, 2023 8-K
27 Apr, 2023 10-K/A
27 Apr, 2023 424B3
10 Apr, 2023 8-K
10 Apr, 2023 424B3
3 Apr, 2023 8-K
3 Apr, 2023 424B3
23 Mar, 2023 EFFECT
17 Mar, 2023 POS AM
16 Mar, 2023 3
8 Mar, 2023 10-K
8 Mar, 2023 8-K
3 Feb, 2023 SC 13G
19 Dec, 2022 4
16 Dec, 2022 4
15 Dec, 2022 4
13 Dec, 2022 4
13 Dec, 2022 4
8 Dec, 2022 4
8 Dec, 2022 4
6 Dec, 2022 4
6 Dec, 2022 424B3
16 Nov, 2022 8-K
14 Nov, 2022 10-Q
14 Nov, 2022 424B3
14 Nov, 2022 8-K
9 Nov, 2022 EFFECT
8 Nov, 2022 CORRESP
8 Nov, 2022 S-1/A
7 Nov, 2022 UPLOAD
4 Nov, 2022 S-1/A
1 Nov, 2022 S-1
21 Oct, 2022 D
21 Oct, 2022 SC 13G
17 Oct, 2022 8-K
20 Sep, 2022 3
20 Sep, 2022 4
13 Sep, 2022 8-K CEO Change
7 Sep, 2022 S-8
18 Aug, 2022 4
15 Aug, 2022 8-K
12 Aug, 2022 10-Q
29 Jul, 2022 8-K
12 Jul, 2022 4
8 Jul, 2022 8-K
7 Jul, 2022 SEC STAFF
7 Jul, 2022 3
7 Jul, 2022 3
7 Jul, 2022 3
7 Jul, 2022 3
7 Jul, 2022 3
7 Jul, 2022 3
7 Jul, 2022 SEC STAFF
7 Jul, 2022 CERT
7 Jul, 2022 3
7 Jul, 2022 3
7 Jul, 2022 3
7 Jul, 2022 3
7 Jul, 2022 3
7 Jul, 2022 3
6 Jul, 2022 CORRESP
1 Jul, 2022 CORRESP
1 Jul, 2022 10-12B/A
30 Jun, 2022 10-12B/A
30 Jun, 2022 UPLOAD
30 Jun, 2022 SEC STAFF
22 Jun, 2022 CORRESP
22 Jun, 2022 10-12B
26 Apr, 2022 UPLOAD
5 Apr, 2022 DRS/A
5 Apr, 2022 DRSLTR
28 Feb, 2022 UPLOAD
28 Jan, 2022 DRS
9 Sep, 2021 D
30 Mar, 2021 D
Last update:2024-03-08 12:06:53.065436
ProMIS Neurosciences Inc. by TradingView

Sign Up to Subscribe